![]() |
|
|
Department of Food Science and Human Nutrition, Iowa State University, Ames, IA 50011
3To whom correspondence should be addressed. E-mail: kschalin{at}iastate.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: retinoic acid S-adenosylmethionine transmethylation glycine N-methyltransferase rats
| INTRODUCTION |
|---|
|
|
|---|
|
Previous work in our laboratory (11
,12)
has demonstrated
that administration of the retinoid 13-cis-retinoic acid
(CRA) results in conditions indicative of enhanced methionine
catabolism. This conclusion is based on our observations that
CRA-treated rats exhibited a significant reduction in both the
hepatic concentration of SAM and the ratio of SAM/SAH. In an attempt to
understand the role of retinoid compounds to alter methionine
metabolism and to induce methyl group loss, the work presented here
focused on activation of GNMT as a potential mechanism. Moreover, we
have extended our work by also evaluating the ability of
all-trans-retinoic acid (ATRA), an active form of vitamin A,
to perturb methyl group metabolism.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents were obtained from the following: S-adenosyl-L-[methyl-3H]methionine, New England Nuclear (Boston, MA); phenylmethylsulfonylflouride, Calbiochem (La Jolla, CA); goat anti-rabbit immunoglobulin G horseradish peroxidase, Southern Biotechnology (Birmingham, AL); ECL Western blotting detection reagents, Amersham Pharmacia (Piscataway, NJ); and S-adenosyl-L-methionine, Sigma Chemical (St. Louis, MO). GNMT antibody was kindly provided by Dr. Conrad Wagner, Vanderbilt University. ATRA and CRA were provided courtesy of Hoffman-LaRoche (Nutley, NJ). All other chemicals were of analytical grade.
Animals and diets.
All animal experiments were approved by and conducted in accordance
with Iowa State University Laboratory Animal Resources Guidelines. Male
Sprague-Dawley (Harlan Sprague-Dawley, Indianapolis, IN) rats
were housed in suspended wire-mesh cages in a room with a 12-h
light:dark cycle and given free access to food and water. The
composition of the control diet was the same as previously described
(11)
. The methionine-supplemented (MS) diet contained
additional L-methionine (10 g/kg diet) at the expense of
glucose monohydrate.
After an 11-d acclimation period during which rats were adapted to both the control diet and the oral administration of corn oil, they were divided into six treatment groups consisting of five rats per group. Rats were fed one of the two diets (control or MS) and were orally given vehicle (corn oil, 1 µL/g body), vehicle containing CRA, or vehicle containing ATRA daily. Both retinoids were administered at a level of 30 µmol/kg of body. After the 7-d treatment period, rats were anesthetized and liver samples were rapidly removed for analysis.
Measurement of GNMT activity.
The enzymatic activity of GNMT was assayed as described by Cook and
Wagner (13)
with minor modifications. Portions of liver
were homogenized in three volumes of ice-cold phosphate buffered
(10 mmol/L, pH 7.0) sucrose (0.25 mol/L) containing 1 mmol/L EDTA, 1
mmol/L sodium azide, and 0.1 mmol/L phenylmethylsulfonylflouride. After
centrifugation at 20,000 x g for 30 min, the resulting
supernatant was removed and 2-mercaptoethanol was added to a final
concentration of 10 mmol/L. The assay mixture consisted of 0.1 mol/L
Tris buffer (pH 9.0), 5 mmol/L dithiothreitol, 1 mmol/L glycine, and 1
mmol/L
S-adenosyl-L-[methyl-3H]methionine
(4.77 x 106 Bq/mmol). The reaction was initiated upon
addition of 250 µg of sample protein. The assay was linear with
respect to time and protein concentration. For the determination of
total soluble protein in the tissue extract, a commercial kit
(Coomassie Plus, Pierce, Rockford, IL) based on the method of Bradford
(14)
was used with bovine serum albumin as a standard.
Measurement of GNMT protein.
For the determination of the abundance of GNMT protein, immunoblotting with chemiluminescence detection was used. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed using a 10%20% gradient gel and 75 µg sample protein per lane. After separation, the proteins were electrophoretically transferred to nitrocellulose and the membrane was incubated at room temperature in a blocking solution containing nonfat dry milk (50 g/L) in Tween 20 + Tris-buffered saline (TTBS) buffer consisting of 20 mmol/L Tris, (pH 7.5) and 500 µl/L Tween 20. Affinity-purified polyclonal GNMT antibody in bovine serum albumin (10 g/L)-TTBS (1:1000) was added and the blot was incubated at 4°C overnight. The blot was incubated for 1 h at room temperature with goat anti-rabbit horseradish peroxidase in TTBS (1:5000), followed by a 1-min incubation in Western blot chemiluminescent detection reagents before multiple exposures to autoradiography film. Densitometric analysis was performed using the National Institutes of Health Image software.
Statistical analysis.
The means of each treatment group were subjected to a two-way
ANOVA. When the ANOVA was significant (P < 0.05),
the means were compared using the Fisher least significant
difference procedure (15)
.
| RESULTS |
|---|
|
|
|---|
Body weights were measured during both the acclimation phase (data not
shown) and retinoid treatment period of the study (Fig. 2
). All rat groups exhibited similar growth patterns regardless of
treatment, and no significant differences were detected in either the
initial (81 ± 2 g) or final (181 ± 3 g) body
weights. As indicated in Figure 2
, no significant differences were
observed in the cumulative weight gain across the treatment groups,
indicating that neither the MS diet nor the retinoids were overtly
toxic to the animals. We have shown previously that administration of
CRA can induce hepatic steatosis in rats fed a similar diet
(12)
. This was also found to be the case in the present
study for both CRA and ATRA (data not shown).
|
Administration of CRA and ATRA consistently elevated the enzymatic
activity of hepatic GNMT (Fig. 3
). For rats fed the control diet, CRA administration increased GNMT
activity 49%. ATRA also increased enzyme activity (34%); however,
this difference was not significant (P = 0.081). In
contrast, both CRA and ATRA significantly induced GNMT activity 41%
and 45%, respectively, in rats fed the MS diet. Adding
L-methionine alone (10g/kg diet) was without
significant effect. Previous studies have demonstrated that induction
of GNMT activity by dietary methionine requires a level closer to 20
g/kg diet (16)
.
|
Using immunoblotting with a GNMT antibody, we determined whether the
retinoid-induced increase in GNMT activity was due to changes in
the production of the enzyme (Fig. 4
). The bar graph reflects the mean result from all of the experimental
animals, whereas the immunoblot shown above is a representative example
with the relative fold induction shown for each lane. Both CRA and ATRA
markedly induced GNMT protein abundance in control rats and in those
receiving the MS diet. The induction of GNMT protein by retinoids
across treatment groups ranged from
8- to 16-fold. Similar to the
enzyme activity data, the MS diet alone did not significantly alter
GNMT protein levels based on mean values. However, it did seem to have
some effect as shown in the representative blot (3.1-fold induction).
There was no difference in actin protein abundance across the treatment
groups. Interestingly, in both the bar graph and representative
immunoblot, the effect of the MS diet and retinoids on GNMT protein
induction appeared to be additive. As suggested by others
(16)
, we have directly confirmed that the addition of
graded levels of L-methionine to the diet and subsequent
induction of GNMT enzyme activity is reflected in an increase in GNMT
protein abundance (Rowling and Schalinske, unpublished data).
|
| DISCUSSION |
|---|
|
|
|---|
In addition, we have extended our earlier observations with CRA
(11
,12)
by demonstrating that ATRA can alter methionine
metabolism and GNMT activity in a similar manner. This has important
nutritional implications, because ATRA represents the active form of
vitamin A for a number of its functions. The retinoid doses used in
this study (30 µmol/kg) are well above the recommended clinical
dosage for humans (26 µmol/kg) as well as the level of vitamin A
provided to rats in the AIN-93G vitamin mix (0.5 µmol/kg). However,
we have found in preliminary dose-response studies that retinoid
doses as low as 1 µmol/kg are sufficient to significantly induce GNMT
(Rowling and Schalinske, unpublished data).
A number of previous studies have reported compounds or conditions that
result in an increase in GNMT activity, including ethanol
administration (17)
and folate deficiency
(18)
. Although folate deficiency increased GNMT activity
as much as 2.6-fold, this increase was not reflected in the abundance
of GNMT protein. Wagner and co-workers (7
,8)
have
demonstrated that GNMT can be negatively and positively regulated by
5-methyl-THF and phosphorylation, respectively, posttranslationally.
Although we have found that retinoids induce GNMT protein abundance and
retinoids are known to function at the transcriptional level, it
remains a possibility that posttranslational control, such as depletion
in 5-methyl-THF, may play a role in this regulation as well. In support
of this possibility, it has been shown that vitamin A status can
influence the one-carbon pool and the distribution of folate
coenzymes, including a depletion of 5-methyl-THF (19
,20)
.
An intriguing possibility exists that the ability of retinoids to
activate GNMT is related to the induction of a gluconeogenic condition.
Xue and Snoswell (21)
reported that GNMT activity was
elevated 65-fold in alloxan-diabetic sheep. Likewise, the report on
phosphoregulation of GNMT (8)
mentioned that enzymatic
activity was increased twofold in diabetic rats. In support of these
findings, it has been shown in rats that GNMT can be found
predominantly in the gluconeogenic tissues liver and kidney, as well as
the pancreas (22)
. In turn, it has been demonstrated that
ATRA regulates phosphoenolpyruvate carboxykinase gene expression
(23)
, the rate-limiting enzyme in gluconeogenesis.
Moreover, it has been shown in vitro that cyclic adenosine
5'-monophosphate-dependent kinases activate GNMT activity via
phosphorylation (8)
; elevations in cyclic adenosine
5'-monophosphate play a role in the stimulation of phosphoenolpyruvate
carboxykinase and during diabetes (24)
.
Certainly a number of potential mechanisms, both transcriptional/translational and posttranslational, may play a role in the retinoid-induced activation of GNMT. Likewise, the possibility that other factors may mediate the ability of retinoids to alter GNMT needs to be considered. Our laboratory is actively pursuing these areas of research as well as determining the consequences of retinoid-induced alterations in transmethylation and possibly folate-dependent one-carbon metabolism. The results of this ongoing research will be important in future dietary recommendations and in the evaluation of retinoid-derived compounds for clinical use.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported in part by Iowa Agriculture and Home Economics Experiment Station (Journal Paper No. J-19189); the Iowa
State University Office of Biotechnology; the Center for Designing Foods to Improve Nutrition (U. S. Department of Agriculture Special Projects Grant 99-03168); U. S. Department of Agriculture NRI 01-35200-09854 (to K.L.S.); and the American Institute for Cancer Research 00B078REV (to K.L.S.). ![]()
4 Abbreviations used: ATRA, all-trans-retinoic acid; CRA, 13-cis-retinoic acid; GNMT, glycine
N-methyltransferase; MS, methionine-supplemented; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; THF, tetrahydrofolate; TTBS, Tween 20 + Tris-buffered saline. ![]()
Manuscript received January 29, 2001. Revision accepted April 18, 2001.
| REFERENCES |
|---|
|
|
|---|
1. Cantoni G. L. S-adenosyl amino acids thirty years later: 19511981. Usdin E. Borchardt R. T. Creveling C. R. eds. The Biochemistry of S-adenosylmethionine and Related Compounds 1982:3-10 Macmillan Press London, England.
2. Cantoni G. L., Chiang P. K. The role of S-adenosylhomocysteine hydrolase in the control of biological methylations. Cavallini D. Gaull G. E. Zappia V. eds. Natural Sulfur Compounds 1980:67-80 Plenum Press New York, NY.
3.
Ghoshal A. K., Farber E. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 1984;5:1367-1370
4. Salmon W. D., Copeland D. H. Liver carcinoma and related lesions in chronic choline deficiency. Ann. N. Y. Acad. Sci. 1954;57:664-677
5. Mason J. B. Folate and colonic carcinogenesis: searching for a mechanistic understanding. J. Nutr. Biochem. 1994;5:170-175
6.
Kerr S. J. Competing methyltransferase systems. J. Biol. Chem. 1972;247:4248-4252
7. Wagner C., Briggs W. T., Cook R. J. Inhibition of glycine N-methyltransferase by folate derivatives: implications for regulation of methyl group metabolism. Biochem. Biophys. Res. Commun. 1985;127:746-752[Medline]
8.
Wagner C., Decha-Umphai W., Corbin J. Phosphorylation modulates the activity of glycine-N-methyltransferase, a folate binding protein: in vitro phosphorylation is inhibited by the natural folate ligand. J. Biol. Chem. 1989;264:9638-9642
9.
Jencks D. A., Matthews R. G. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. J. Biol. Chem. 1987;262:2485-2493
10. Kutzbach C., Stokstad E.L.R. Feedback inhibition of methylenetetrahydrofolate reductase: partial purification properties, and inhibition by S-adenosylmethionine. Biochim. Biophys. Acta 1967;250:459-477
11. Schalinske K. L., Steele R. D. 13-cis-Retinoic acid alters methionine metabolism in rats. J. Nutr. 1991;121:1714-1719
12. Schalinske K. L., Steele R. D. 13-cis-Retinoic acid and hepatic steatosis in rats. Biochem. Pharmacol. 1993;46:319-325[Medline]
13.
Cook R. J., Wagner C. Glycine N-methyltransferase is a folate binding protein of rat liver cytosol. Proc. Natl. Acad. Sci. U.S.A. 1984;81:3631-3634
14. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal. Biochem. 1976;72:248-254[Medline]
15. Snedecor G. W., Cochran W. G. Statistical Methods 7th ed. 1980 Iowa State University Press Ames, IA.
16. Ogawa H., Fujioka M. Induction of rat liver glycine methyltransferase by high methionine diet. Biochem. Biophys. Res. Commun. 1982;108:227-232[Medline]
17. Trimble K. C., Molloy A. M., Scott J. M., Weir D. G. The effect of ethanol on one-carbon metabolism: increased methionine catabolism and lipotrope methyl-group wastage. Hepatology 1991;18:984-989
18. Balaghi M., Horne D. W., Wagner C. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem. J. 1993;291:145-149
19. Fell D., Steele R. D. Enhancement of histidine and one-carbon metabolism in rats fed high levels of retinol. J. Nutr. 1982;112:474-479
20. Fell D., Steele R. D. Modification of hepatic folate metabolism in rats fed excess retinol. Life Sci 1986;38:1959-1965[Medline]
21. Xue G.-P., Snoswell A. M. Disturbance of methyl group metabolism in alloxan-diabetic sheep. Biochem. Int. 1985;10:897-905[Medline]
22.
Yeo E.-J., Wagner C. Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. Proc. Natl. Acad. Sci. U.S.A. 1994;91:210-214
23.
Shin D.-S., McGrane M. M. Vitamin A regulates genes involved in hepatic gluconeogenesis in mice: phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase, and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. J. Nutr. 1997;127:1274-1278
24.
Jefferson L. S., Exton J. H., Batchy R. W., Sutherland E. W., Park C. R. Role of adenosine-3',5'-monophosphate in the effects of insulin and anti-insulin serum on liver metabolism. J. Biol. Chem. 1968;243:1031-1038
This article has been cited by other articles:
![]() |
K. T. Williams, T. A. Garrow, and K. L. Schalinske Type I Diabetes Leads to Tissue-Specific DNA Hypomethylation in Male Rats J. Nutr., November 1, 2008; 138(11): 2064 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Beagle, T. L. Yang, J. Hung, E. A. Cogger, D. J. Moriarty, and M. A. Caudill The Glycine N-Methyltransferase (GNMT) 1289 C->T Variant Influences Plasma Total Homocysteine Concentrations in Young Women after Restricting Folate Intake J. Nutr., December 1, 2005; 135(12): 2780 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Tanghe, T. A. Garrow, and K. L. Schalinske Triiodothyronine Treatment Attenuates the Induction of Hepatic Glycine N-Methyltransferase by Retinoic Acid and Elevates Plasma Homocysteine Concentrations in Rats J. Nutr., November 1, 2004; 134(11): 2913 - 2918. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Nieman, M. J. Rowling, T. A. Garrow, and K. L. Schalinske Modulation of Methyl Group Metabolism by Streptozotocin-induced Diabetes and All-trans-retinoic Acid J. Biol. Chem., October 29, 2004; 279(44): 45708 - 45712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Ozias and K. L. Schalinske All-trans-Retinoic Acid Rapidly Induces Glycine N-methyltransferase in a Dose-Dependent Manner and Reduces Circulating Methionine and Homocysteine Levels in Rats J. Nutr., December 1, 2003; 133(12): 4090 - 4094. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rowling and K. L. Schalinske Retinoic Acid and Glucocorticoid Treatment Induce Hepatic Glycine N-Methyltransferase and Lower Plasma Homocysteine Concentrations in Rats and Rat Hepatoma Cells J. Nutr., November 1, 2003; 133(11): 3392 - 3398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-L. Tseng, Y.-P. Shih, Y.-C. Huang, C.-K. Wang, P.-H. Chen, J.-G. Chang, K.-T. Yeh, Y.-M. A. Chen, and K. H. Buetow Genotypic and Phenotypic Characterization of a Putative Tumor Susceptibility Gene, GNMT, in Liver Cancer Cancer Res., February 1, 2003; 63(3): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rowling, M. H. McMullen, D. C. Chipman, and K. L. Schalinske Hepatic Glycine N-Methyltransferase Is Up-Regulated by Excess Dietary Methionine in Rats J. Nutr., September 1, 2002; 132(9): 2545 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rowling, M. H. McMullen, and K. L. Schalinske Vitamin A and Its Derivatives Induce Hepatic Glycine N-Methyltransferase and Hypomethylation of DNA in Rats J. Nutr., March 1, 2002; 132(3): 365 - 369. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||